YOLANDE JACKSON: Open Payments
NPI 1164273173 · CONYERS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,890 in 88 payments from 24 companies in 2025. Trend: 2023 $0 · 2024 $361 · 2025 $1,890
Food & beverage: $1,890
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 17 | $237 |
| ABBVIE INC. | 13 | $197 |
| ACADIA Pharmaceuticals Inc | 7 | $186 |
| Otsuka America Pharmaceutical, Inc. | 5 | $176 |
| Neurelis, Inc. | 6 | $152 |
| Biogen, Inc. | 7 | $136 |
| Neurocrine BioSciences, Inc. | 4 | $106 |
| Novartis Pharmaceuticals Corporation | 3 | $87 |
| Lundbeck LLC | 3 | $77 |
| Janssen Biotech, Inc. | 2 | $67 |
Products named: REXULTI, NUPLAZID, QULIPTA, VALTOCO, INGREZZA, KESIMPTA, Rystiggo, Briviact.
Industry payments across GA — which companies pay providers there.
